M1 Polarization Markers Are Upregulated in Basal-Like Breast Cancer Molecular Subtype and Associated With Favorable Patient Outcome

BACKGROUND: Breast cancer heterogeneity is an essential element that plays a role in the therapy response variability and the patient’s outcome. This highlights the need for more precise subtyping methods that focus not only on tumor cells but also investigate the profile of stromal cells as well as...

Descripción completa

Detalles Bibliográficos
Autores principales: Hachim, Mahmood Yaseen, Hachim, Ibrahim Yaseen, Talaat, Iman M., Yakout, Nada M., Hamoudi, Rifat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701279/
https://www.ncbi.nlm.nih.gov/pubmed/33304345
http://dx.doi.org/10.3389/fimmu.2020.560074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701279/
https://www.ncbi.nlm.nih.gov/pubmed/33304345
http://dx.doi.org/10.3389/fimmu.2020.560074

Ejemplares similares